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Introduction
Leptin is an adipocyte-derived hormone/cytokine that links nutritional status with neuroendocrine and immune functions 1 . Acting on its receptors in the hypothalamus leptin is a key player in regulating energy intake and expenditure 2, 3 . Besides reflecting the amount of energy stored in the adipose tissue, leptin modulates the function of a wide variety of cell types 4 . The full-length form of the leptin receptor (ObRb) is known to be predominantly responsible for active signal transduction leading to modification of intracellular lipid metabolism, activation of several downstream pathways, such as the STAT-3 and the IRS1/PI3K/Akt/NF-κB ones, and an increased production of pro-inflammatory chemokines [5] [6] [7] . In addition, leptin increases the expression levels of enzymes involved in the production of inflammatory mediators 8, 9 thus providing an important cross-talk between lipid metabolism and inflammation at the cellular level.
Sebaceous glands and hair follicles form together the pilosebaceous units, whose primary function is the production of sebum 10 . While an altered lipid composition associated with an increased excretion of sebum is one of the most important factors in the development of acne, on the other hand, its impaired production has been proposed as a key feature in atopic dermatitis 11 . Sebaceous glands also play a central role in skin inflammation 10, 12 . Pattern recognition receptors such as TLR2, TLR4, and TLR6 are expressed in sebocytes 13, 14 , and their activation increases the secretion of both pro-and anti-inflammatory cytokines (IL-6 and IL-10 respectively), chemokines (IL-8), antimicrobial lipids, peptides, periglandular peptides and neuropeptides 15-17 . This article is protected by copyright. All rights reserved.
It is conceivable, therefore, that known signalling mechanisms that mediate leptin actions may also be active in sebocytes. Indeed, sebocytes provide an interesting cell model to study abundant, primary lipogenesis and mediation of inflammatory responses 18 .
In this study, we provide evidence that the functionally active full-length form of the leptin receptor (Ob-Rb) is expressed in human sebaceous glands and in cultured human SZ95 sebocytes and present a systematic analysis on the effect of leptin on SZ95 sebocytes regarding lipogenesis and inflammation.
Materials and methods

Immunohistochemistry, immunocytochemistry
Anonymised formalin-fixed and paraffin embedded sections of human skin from the tissue archive of the Department of Dermatology, University of Debrecen were acquired after the approval of the Regional and
Institutional Ethics Committee, University of Debrecen. SZ95 sebocytes were cultured in chamber slides (LabTek, Thermo Scientific, Rochester, NY), in a density of 10,000 cells/well. Immunohistochemistry and immunocytochemistry was carried out by using a purified primary antibody to the functionally active full length form of the leptin receptor (Ob-Rb; 250739, Abbiotec, San Diego, CA). Staining protocols are presented in supplementary information online.
Cell culture and cell treatment
The immortalized human sebaceous gland cell line SZ95 was cultured as described previously 19 . Human recombinant leptin (R&D Systems, Minneapolis, MN) was dissolved and stored at −70°C according to the manufacturer's protocol. For an optimal stimulation, leptin was used at the concentration of 20 nM, which is within the normal range of human serum levels 6 . Leptin was monitored for endotoxin contamination using the Limulus Endosafe ® KTA2™ assay (Charles River Endosafe, Charleston, SC).
The endotoxin level was <0.02 EU per 1 μg. Parallel experiments were performed using equivalent levels of lipopolysaccharides (LPS; 3 pg/ml) that did not result in lipid body enlargement or in STAT3 and p65 phosphorylation (Supplement 1) and did not induce the expression levels of COX-2 or 5-LOX proteins.
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Lipid analyses
SZ95 sebocytes were cultured in epidermal growth factor-free medium, harvested at the indicated time points, then counted and stored at -80°C until processing. Lipid extraction was performed as previously reported with slight modifications to adapt it to a multiple lipid analyses protocol 20 (Supplementary information online).
Lipid body detection and enumeration
Sebocytes were cultured on LabTek chamber slides (Thermo Scientific) and were treated with human recombinant leptin, for 12 and 24 h. Lipid bodies with size over 3 m in SZ95 sebocyte colonies were enumerated with a ×100 objective lens for 100 consecutive cells in each slide (Supplement 2). Staining protocols and information on microscopes and acquisition software are detailed in Supplementary information online.
Western blotting
Cells were collected at the indicated time points and processed for western bloting according to the 
ELISA
Supernatants of SZ95 sebocyte cultures maintained with/without leptin were collected at the indicated time points and were stored at −20°C until they were analyzed for the presence of IL-6, IL TNF and This article is protected by copyright. All rights reserved.
IL-1. Cytokine levels were measured using Quantikine ELISA reagents (R&D systems) according to the manufacturer's instructions.
Quantitative real-time PCR (qRT-PCR)
To obtain total RNA, cells were centrifuged and pelleted at the indicated time points. RNA isolation, cDNA synthesis, qRT-PCR, used assays and quantification methods are detailed in Supplementary information online.
Statistical analyses
All data are presented as mean ± SD. In qRT-PCR experiments, the mean and SD were calculated for both the normalized and the normalizer values. To incorporate the random errors of the measurements, we used the propagation of errors to determine the SD of the normalized values. We made at least four biologic replicates for all experiments. In qRT-PCR experiments, we performed an unpaired, two-tailed, t test. Differences with p0.05 values were considered statistically significant.
Results
Ob-Rb is expressed in human sebaceous glands
To address the possible role of leptin signalling in sebaceous gland biology, we first performed immunohistochemical analysis using a specific antibody for the Ob-Rb receptor subtype, which is responsible for active signal transduction in human skin samples of healthy individuals and acne patients.
We found that Ob-Rb was expressed in the sebaceous glands of both the healthy, as well as the acneinvolved skin (Fig. 1a, b) .
Next, we turned our attention to human SZ95 sebocytes and used qRT-PCR, western blotting and immunohistochemical analyses to detect the expression of Ob-Rb at mRNA and protein levels. We found that Ob-Rb mRNA levels in SZ95 sebocytes were comparable with the levels detected in a human This article is protected by copyright. All rights reserved.
immortalized keratinocyte cell line (HaCaT), in primary human keratinocytes (NHEK), as well as in human blood derived monocytes/macrophages (Fig. 1c ).
In line with the mRNA analysis, the expression of the Ob-Rb protein was detected by western blotting using an antibody that detected also the Ob-Ra variant (Fig. 1d) . These results were later confirmed by immunostaining using an antibody specific for the Ob-Rb isoform (Fig. 1e ).
These findings confirmed SZ95 sebocytes as a valuable model for further investigations on addressing the role of leptin in sebocyte biology.
Leptin alters lipogenesis in SZ95 sebocytes
The primary function of sebocytes is their potential to synthetize lipids, therefore we investigated the early and late effects of leptin on the lipid profile of leptin-treated SZ95 sebocytes, assessing the synthesis of major sebaceous lipids such as squalene (SQ), cholesterol (CH), triglycerides (TG), free fatty acids (FFA), as well as alpha-tocopherol (vitamin E, VE). Briefly, cell samples were collected at 12 and 36 h after leptin treatment and compared to controls using various techniques such as high performance thin layer chromatography (HPTLC), gas-chromatography-mass spectrometry (GC-MS) and high performance liquid chromatography coupled with flight mass spectrometer mass detector (HPLC-ToF/MS).
First, HPTLC with densitometric analysis showed that TG levels were significantly elevated in response to leptin at 36 h (+ 37%); in contrast to SQ, FFA and CH levels that did not change significantly (Fig. 2a) . For a higher sensitivity and specificity, SQ and CH levels were simultaneously quantified by GC-MS. The extended analysis showed that while SQ levels were not modified over time in control sebocytes, its concentration tended to increase in the leptin-treated ones. In contrast, concentration of CH increased in a time-dependent manner in both the control and leptin-treated cells, and leptin treatment did not result in any significant change compared to the controls (Supplement 3).
Next, in order to further investigate representative components of the human sebum such as different
FFAs and TG lipid classes, samples were analyzed by HPLC-ToF/MS and GC-MS 21 . The evaluation of the summarized levels and calculated ratios of monounsaturated fatty acids/saturated fatty acids This article is protected by copyright. All rights reserved.
(MUFA/SFA) and polyunsaturated fatty acids/saturated fatty acids (PUFA/SFA) showed significant differences in the PUFA/SFA ratios (control vs. leptin at 36 h, p<0.05) and was close to significance regarding the MUFA/SFA ratios (control vs. leptin at 12 h, p=0.07) (Fig. 2b) . The change of the cell redox status consequent to activation of lipid synthesis has barely been investigated in sebocytes. Thus, VE, which accounts for the major lipid scavenger of free radicals in the cell membrane, was also analyzed. The concentration of VE was significantly lower in leptin-treated sebocytes at 36 h (Fig. 2d ).
These data indicate that desaturation of FFA is an early effect of leptin treatment, whereas appreciable induction of TG synthesis occurs at later time points. Moreover a significant decrease in the VE levels indicated that leptin and its lipogenic effects could be associated with consumption of lipophilic antioxidants.
Leptin treatment leads to lipid body enlargement in SZ95 sebocytes
Sebocytes store and metabolize intracellular lipids in hydrophobic organelles called lipid bodies. In order to detect changes in the lipid body formation we used fluorescent microscopy to visualize the BODIPY stained lipid droplets ( Fig. 3a-b) . As sebocytes accumulate lipid droplets in high numbers with different sizes, we focused on the lipid droplets exceeding 3 m of size. We found that in the leptin-treated samples the number of cells with such lipid droplets was increased when compared with the untreated controls (Fig. 3c ). As BODIPY staining is able to selectively stain lipid droplets it also allows FACS measurements for quantitative analyses 22 . In support to the previous findings, we confirmed that leptintreated SZ95 sebocytes exhibited an increased fluorescence intensity compared to control cells (Fig. 3d ).
Altogether, these results indicate that leptin-treated SZ95 sebocytes display an altered lipid droplet formation.
COX-2 and 5-LOX expression and inflammatory cytokine expression of SZ95 cells is increased by leptin
To investigate the potential role of leptin in inflammation, first we measured the protein levels of COX-2 and 5-LOX, the key enzymes in the production of inflammatory mediators in SZ95 sebocytes. Using western blot analysis we could show that the expression levels of COX-2 ( Fig. 4a ) and 5-LOX (Fig. 4b) were increased upon leptin treatment when compared to untreated cells.
Next, we determined the effect of leptin on the expression of IL-6 and IL-8, shown to be important in the inflammatory signalling of human sebocytes 10, 15 . In the presence of leptin the mRNA levels of both IL-6 and IL8 showed a marked up-regulation compared to untreated cells (Fig. 4d) . Similar to this, the secreted IL-6 and IL-8 protein levels were also up-regulated, as detected by ELISA measurements (Fig.   4e ). On the other hand, we could not detect secretion of TNFα and IL1β by ELISA in any of the tested conditions, a finding that is consistent with previous reports suggesting that SZ95 sebocytes do not secrete these cytokines under normal conditions 16, 23 .
To exclude that the measured differences were related to a reduced cell viability we also performed an apoptosis assay at 12, 24 and 48 h time points and found no differences between the leptin-treated and the untreated control cells (Supplement 4).
These data altogether show that SZ95 sebocytes respond to leptin stimulus with an enhanced expression of inflammatory enzymes and an increased production and secretion of pro-inflammatory cytokines.
Leptin activates STAT-3 and NF-B pathways in SZ95 sebocytes
The prime consequence of leptin binding to its receptor is the activation of the STAT-3 pathway leading to STAT-3 phosphorylation 24 , while on the other hand, NF-B also serves as a downstream signalling This article is protected by copyright. All rights reserved.
mediator of leptin 25 . To explore the mechanisms by which leptin could increase the inflammatory response of SZ95 sebocytes we examined its effect on STAT-3 and NF-B activation. We measured and compared the intensity and length of the phosphorylation of STAT-3 and the NF-B p65 subunit in the control and leptin-treated SZ95 sebocytes during a 1-hour time period. Upon leptin treatment, both STAT-3 and p65 phosphorylation increased (Fig. 4c) , showing that this treatment resulted in an increased STAT-3 and NF-B activity.
These data suggest that leptin contributes to inflammation through the induction of STAT-3 and NF-B signalling in SZ95 sebocytes.
Discussion
Sebaceous glands play a pivotal role in the development of the intact skin barrier through the production of sebum. Moreover, besides their active lipid metabolism [26] [27] [28] , sebocytes also play an important role in the setting of an inflammatory environment by being competent for the synthesis and secretion of proinflammatory cytokines, such as IL-6 and IL-8. As a result, they are involved in the initiation of the pathogenesis of sebaceous gland associated diseases such as acne 18, [29] [30] [31] .
Leptin is an adipokine, secreted predominantly by adipocytes in response to increased lipid uptake 32 .
Its serum concentration correlating with the body mass index, and the amount of the adipose tissue is responsible for its systemic effects through the leptin receptor in the hypothalamus. However, the role of leptin is not limited to the regulation of energy expenditure. 38 , fibroblasts 39 and keratinocytes 40 all seem to respond to leptin.
Regarding its role in skin physiology, leptin was found to be an important player in skin regeneration and ageing, as well as in hair growth 39, 41, 42 . Considering the complex role of leptin in integrating lipid metabolism and inflammatory responses at a cellular level, it is intriguing to speculate that leptin signalling could be implicated into sebocyte biology, too. Supporting this hypothesis, leptin deficient This article is protected by copyright. All rights reserved.
(ob/ob) mice were found to exhibit an increased sebaceous gland size 43 with an abnormal production of type II wax diesters, which are important for water repulsion in mice 44 . However, using HE-stained sections for sebaceous gland size measurements and considering the fact that mouse sebum greatly differs from the human one (e.g. contains relatively small amounts of triglycerides 45 ) conclusions are not easy to be made regarding human sebocyte biology. Moreover, the unavailability of animal models that exert sebaceous gland-associated human diseases, like acne, further suggests that besides the function also the pathology of sebaceous glands have changed with evolution. These findings altogether point towards a possible role for leptin in sebocyte biology, but call for further, cell-type specific studies on how leptin affects lipogenesis and inflammation in the human sebaceous cells.
In our work evidence is provided that leptin receptor is expressed in the human sebaceous glands, besides the human epidermis 39 , human follicular papilla cells 46 and the sebocyte-like cells of the rat preputial gland 47 , where it was previously detected. Interestingly, the expression of the Ob-Rb receptor was detected both in control and in acne samples, suggesting that these cells can readily respond to leptin under different conditions. In order to investigate how leptin could alter lipogenesis and inflammation in human sebocytes, we confirmed initially the presence of Ob-Rb in SZ95 sebocytes, followed by a comprehensive analysis of the outcomes of leptin stimulus, by measuring the changes in the lipid body formation, lipid profile and the pro-inflammatory responses with the possible signalling pathways behind it (Fig. 5 ).
Lipid body formation is a phenomenon widely observed in lipid-metabolizing cells, however, their presence and dynamics have only been studied to a limited extent in these cell types 20 . Using BODIPY fluorescent staining, we found that leptin treatment was associated with an enlargement of the lipid droplets and increased fluorescence intensity within SZ95 sebocytes. Interestingly, the same phenomenon could also be observed in macrophages upon leptin treatment 48 , pointing out that leptin could affect intracellular lipid storage and metabolism, and depending on the cell type and model system used, lipolysis is not an obligate outcome alone. Noteworthy, the mechanisms controlling the formation of lipid bodies and the fate of intracellular lipids are likely to be influenced by the specific functions that the This article is protected by copyright. All rights reserved. different tissues carry out, e.g. the adipose tissue accumulates lipids to store excessive energy, whereas lipids being synthetized in the sebaceous glands are excreted to form the skin surface lipid film 49 .
Moreover, a possible link between lipid body enlargement and sebum production was already addressed in a recent publication that aimed to characterize sebocytes of Cidea-deficient mice that exerted markedly reduced levels of skin surface lipids. While Cidea-deficient sebocytes with an impaired lipid production and secretion accumulated a large number of smaller-sized lipid droplets, the overexpression of Cidea in human SZ95 sebocytes resulted in an increased lipid storage and in an accumulation of large lipid droplets that were both correlated positively with human sebum secretion. 50 These results put forward that in the leptin-treated sebocytes the enlargement of lipid droplets could be considered as a marker for increased lipid production and secretion, however more data on the formation, enlargement, function and fate of these lipid bodies are needed to understand their exact role in (leptin-treated) sebocytes.
In order to detect the changes in the levels of lipids that are present in the human sebum, we exploited additional lipidomic analyses 21 and provided evidence that similarly to other cell types capable of responding to leptin stimulus, leptin altered lipogenesis in SZ95 sebocytes, too. In this process desaturation of FFA might be a key event as revealed by the relative accumulation of different MUFAs and PUFAs. Furthermore, the increased ratios of the unsaturated/saturated FFA could explain the increased levels of TG at the later time points and also the enlargement of lipid bodies as unsaturated FFA were shown to induce TG at greater extents than the saturated ones and promoted TG-enriched lipid body formation in different cell types 51 .
Giving biological relevance to these findings, the importance of the unsaturated/saturated lipid ratio in the sebum was addressed in a former publication showing that a decrease in unsaturated FFA vs. saturated FFA levels in sebum, especially marked by the FFA 16:1/16:0 ratio, was predictive of the clinical improvement in acne, suggesting that the desaturation of sebaceous fatty acids may be involved in acne development 52 . Interestingly, the authors also found that acne subjects on low glycemic load diet (LGL)
showed a greater improvement, which correlated with the change in body mass and with the decrease in the levels of unsaturated FFA compared to the increase seen in the control group of patients on non This article is protected by copyright. All rights reserved.
LGL 52 . Concluding their findings, they hypothesized that LGL diet may affect sebum composition via undefined metabolic effects in which, according to our understanding, leptin may be a key candidate. In our system, supporting this notion, we provide evidence that leptin might be implicated into the pathophysiology of acne by inducing an "acne-like" change in the sebaceous lipid profile via increasing the amounts of unsaturated FFA, especially the FFA 16:1/16:0 ratio, which largely resembles the changes in the composition of sebum found in acne patients. Moreover, the decrease in the levels of the major sebum antioxidant VE upon leptin treatment, which is also a hallmark in acne patients 39 , further supports a possible role for leptin in acne.
Multiple lines of evidence indicate that the role of sebocytes is not limited to lipogenesis, but is also the modulation of inflammation. Previous reports have shown that, just as it was detected in the sebaceous glands of acne lesions, SZ95 sebocytes also express inflammatory enzymes (COX-2 and 5-LOX), cytokines (IL-6) and chemokines (IL-8) at a basal level 15 . Moreover, their expression could be further induced upon treatment with various inflammatory stimuli including arachidonic acid, linoleic acid 53 , and P. acnes 16 . We showed that the expression of all these molecules were significantly increased upon leptin treatment supporting that leptin might also be a potential player in inducing inflammatory signalling in human sebocytes.
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